- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Insider Buying
Global Pharmaceuticals & Biotech High Insider Buying
Results
149
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
149 companies
CTT Pharmaceutical Holdings
Market Cap: US$3.2m
Engages in the development of oral drug delivery systems for pain management and treatment.
CTTH
US$0.057
7D
-16.1%
1Y
128.0%
Neural Therapeutics
Market Cap: CA$2.5m
A drug discovery company, focuses on plant-based active substances.
NURL
CA$0.01
7D
-33.3%
1Y
n/a
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%
Jolt Health
Market Cap: CA$1.1m
Operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada.
JOLT
CA$0.085
7D
6.3%
1Y
-15.0%
Nirvana Life Sciences
Market Cap: CA$684.7k
Engages in the research and development of therapeutic products and medicines to address addiction.
NIRV
CA$0.03
7D
-64.7%
1Y
n/a